Onco-Nutrition and Supplements Market Size - Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2025 – 2034

Onco-Nutrition and Supplements Market Size

The global onco-nutrition and supplements market generated notable revenues in 2024 and is projected to continue to grow at a decent CAGR between 2025-2034, driven by the increasing prevalence of cancer, and a growing understanding of the role of nutrition in cancer treatment. As per the American Cancer Society in 2024, the United States had 2,001,140 new cancer cases and 611,720 cancer deaths. Cancer patients experience cachexia, malnutrition, weight loss, and muscle wasting due to the cancer and/or its treatments. Nutritional supplements targeted for cancer care, or onco-nutrition, help improve patient outcomes by functioning as support for improving immunity, maintaining lean body mass, and preserving the quality of life during and after treatment.
 

Many new cancer care models promote a fully integrated holistic approach with dietary support during medical therapies making targeted comprehensive nutritional interventions a significant and essential part of recovery. The market for onco-nutrition supplements is also seeing an increasing demand for personalized nutrition solutions specific to the type and stage of cancer. As healthcare providers increasingly recognize the importance of supportive care, onco-nutrition is emerging as an integral part of a complete oncology care pathway.
 

In addition, the rapidly increasing aging population is more susceptible to cancer, and outpatient treatment solutions are growing for cancer treatments expanding the market. Uncertainties surround market challenges, including rising prices and costs, lack of clinical guidelines and standards of practice, and maxed-out time, effort, and financial resources on the part of patients.
 

Onco-Nutrition and Supplements Market Trends

There are many emerging trends that are providing indications of how the onco-nutrition and supplements industry might evolve. One notable trend is the increasing demand for personalized (and cancer-specific) nutrition plans. With specificity in precision medicine growing, more nutritional interventions are being personalized to the patient's specific needs, cancer type, stage of treatment, and metabolic outcomes. Another growing trend is using plant-based and natural supplement formulations that provide immune modulation and inflammatory effects without side effects.
 

Digital health and remote monitoring tools are another growing trend to allow dietitians and oncologists to monitor nutrition status continuously, as well as adapt the nutrition intake, which improves adherence to the nutrition plan. Coincidently, the movement toward home-based cancer care, especially in developed markets, has increased demand for easily consumable, ready-to-drink formulations or supplement packs that provide things that can be readily self-administered by the patient.
 

The continuing research supporting the role of onco-nutrition in improving patient survival, tolerability to treatment, and rate of recovery has pushed hospitals and oncology centers to deploy formalized nutrition support programs. There is additional emphasis placed by pharmaceutical and nutrition companies on fortification, especially with omega-3 fatty acids, amino acids, and antioxidants. Therefore, onco-nutrition is signaling a future where nutrition is more supported and acknowledged in the oncology support pathway.
 

Onco-Nutrition and Supplements Market Analysis

The onco-nutrition and supplements industry for head and neck cancer segment witness robust growth in 2024. Head and neck cancer patients undergo a range of treatments, each of which may cause significant functional deficits concerning eating and swallowing. These challenges could be due to surgery, complications resulting from radiation treatment, such as mucositis and xerostomia (dry mouth), or an altered sense of taste. These issues increase the risk for malnutrition, and malnutrition may impair immune function and adversely affect the effectiveness of cancer treatment. Consequently, nutritional support is a foundational part of managing the care of this patient population. In considering nutritional support and supplements for patients with head and neck cancer, we can use onco-nutrition and provide high-calorie, high-protein supplements and specialty formulations to ensure the products we provide can be swallowed and digested without significant effort. There are products with neutral or mild flavor profiles, which are increasingly important for patients who have taste sensitivity and oral discomfort. Additionally, many patients have been fed through nasogastric or gastrostomy tubes, particularly in cases where they have advanced cancer, and the patient requires a liquid formulation compatible with their enteral feeding.
 

The hospitals segment accounted for the largest share in 2024 and is forecast to continue leading through 2034. Hospitals are where cancer diagnosis, treatment, and nutritional management take place, and the oncology units of hospitals will typically be staffed with multidisciplinary teams, including dietitians and clinical nutritionists, who are tasked with assessing the patients' nutritional status and prescriptions for supplements. A hospital monitors the patients' progress modifies a nutrition care plan in real-time and provides both oral and enteral feeding therapies.
 

Hospitals have access to more complex diagnostics and lab services that enable a more thorough approach to nutrition care, which includes monitoring inflammation muscle mass, and metabolic responses. Hospitals also have access to a larger pool of dietary nutrition products on the market that are approved in clinical nutrition applications or medically driven applications (with Procurement Agreements) with top nutrition companies and pharmaceutical companies.
 

North America onco-nutrition and supplements market is projected to hold its position through 2034 due to several factors, including a high incidence of cancer, established healthcare infrastructure, and a strong reimbursement system. The larges part of this market is expected to come from the US. Cancer is reportedly the second leading cause of morbidity and mortality, thus it remains a concern across the entire healthcare system. Nutrition has also begun to be integrated into standard treatment regimens for oncology patients, thus supporting the historical evidence that early and targeted nutritional intervention can improve patient outcomes.
 

The likelihood that many clinical trials for nutrition therapies occur in North America is also notable given the high-level of specialized cancer care and cancer care research institutions. Onco-nutrition services, including onco-nutrition services covered by Medicare under medical nutrition therapy, are supported by private and government payers, thus inflating market potential. The wide availability of varied and cutting-edge nutritional products, including organic and plant-based, presents substantial options for patients and their providers.
 

Onco-Nutrition and Supplements Market Share

The onco-nutrition and supplements industry key players include:
 

• Nestle S.A.
• Hormel Foods
• Danone
• B. Braun Melsungen AG
• Global Health Products
• Abbott
   

Major companies are implementing several plans to bolster their presence. Product innovation is one of the main priorities, and they are creating more nutrient-dense formulations that are easy to consume and specific to cancers and side effects of treatment. And many are conducting clinical data to demonstrate products and approve them for 'medical purposes' use. These companies, where appropriate, are also building strategies toward partnerships that allow integration into hospitals and oncology clinics and with larger research institutions. Many are using acquisition mergers and partnerships to expand their geographic coverage to regions with limited access. Some companies are investing in a digital transformation strategy, including health apps for food tracking, or nutrition programs or systems that use AI to allow patients and their plans to better integrate and adhere to nutritional plans.
 

Onco-Nutrition and Supplements Industry News

• In May 2025, My Doctor’s Recipe launched Nutri-Ice®, a handmade frozen supplement from Kent, designed to support recovery and well-being. It was developed by oncologists, nutritionists, and chefs, especially for people undergoing cancer treatment. It combined clinical nutrition with enjoyable flavor—that could truly change therapeutic nutrition.
   
• In March 2025, SurvivorRx, the first wellness brand created specifically for cancer survivors. It included supplements and resources designed to support whole-body health. With input from oncologists, pharmacists, and naturopaths, it offered a personalized, holistic approach that also included education and community support.